Oncogene Riedel, M, Berthelsen, M F, Cai, H, Haldrup, J, Borre, M, Paludan, S R, Hager, H, Vendelbo, M H, Wagner, E F, Bakiri, L & Thomsen, M K 2021, ' In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun ', Oncogene, vol. 40, pp. 2437-2447 . https://doi.org/10.1038/s41388-021-01724-6 Riedel, M, Berthelsen, M F, Cai, H, Haldrup, J, Borre, M, Paludan, S R, Hager, H, Vendelbo, M H, Wagner, E F, Bakiri, L & Thomsen, M K 2021, ' In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun ', Oncogene, vol. 40, no. 13, pp. 2437–2447 . https://doi.org/10.1038/s41388-021-01724-6
Haldrup, J, Strand, S H, Cieza-Borrella, C, Jakobsson, M E, Riedel, M, Norgaard, M, Hedensted, S, Dagnaes-Hansen, F, Ulhoi, B P, Eeles, R, Borre, M, Olsen, J V, Thomsen, M, Kote-Jarai, Z & Sorensen, K D 2021, ' FRMD6 has tumor suppressor functions in prostate cancer ', Oncogene, vol. 40, no. 4, pp. 763–776 . https://doi.org/10.1038/s41388-020-01548-w Haldrup, J, Strand, S H, Cieza-Borrella, C, Jakobsson, M E, Riedel, M, Norgaard, M, Hedensted, S, Dagnaes-Hansen, F, Ulhoi, B P, Eeles, R, Borre, M, Olsen, J, Thomsen, M, Kote-Jarai, Z & Sorensen, K D 2021, ' FRMD6 has tumor suppressor functions in prostate cancer ', Oncogene, vol. 40, pp. 763-776 . https://doi.org/10.1038/s41388-020-01548-w
Berthelsen, M F, Riedel, M, Cai, H, Skaarup, S H, Alstrup, A K O, Dagnæs-Hansen, F, Luo, Y, Jensen, U B, Hager, H, Liu, Y, Callesen, H, Vendelbo, M H, Jakobsen, J E & Thomsen, M K 2021, ' The crispr/cas9 minipig : a transgenic minipig to produce specific mutations in designated tissues ', Cancers, vol. 13, no. 12, 3024 . https://doi.org/10.3390/cancers13123024 Cancers, Vol 13, Iss 3024, p 3024 (2021) Berthelsen, M F, Riedel, M, Cai, H, Skaarup, S H, Alstrup, A K O, Dagnæs-Hansen, F, Luo, Y, Jensen, U B, Hager, H, Liu, Y, Callesen, H, Vendelbo, M H, Jakobsen, J E & Thomsen, M K 2021, ' The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues ', Cancers, vol. 13, no. 12, 3024 . https://doi.org/10.3390/cancers13123024 Berthelsen, M F, Riedel, M, Cai, H, Skaarup, S H, Alstrup, A K O, Dagnæs-Hansen, N F, Luo, Y, Jensen, U B, Hager, H, Liu, Y, Callesen, H, Vendelbo, M, Jakobsen, J E & Thomsen, M K 2021, ' The CRISPR/Cas9 minipig-a transgenic minipig to produce specific mutations in designated tissues ', Cancers, vol. 13, pp. 3024 . https://doi.org/10.3390/cancers13123024 Cancers Volume 13 Issue 12
Berthelsen, M F, Leknes, S L, Riedel, M, Pedersen, M A, Joseph, J V, Hager, H, Vendelbo, M H & Thomsen, M K 2021, ' Comparative analysis of Stk11/Lkb1 versus Pten deficiency in lung adenocarcinoma induced by CRISPR/Cas9 ', Cancers, vol. 13, no. 5, 974 . https://doi.org/10.3390/cancers13050974 Cancers Berthelsen, M F, Leknes, S L, Riedel, M, Pedersen, M A, Joseph, J V, Hager, H, Vendelbo, M H & Thomsen, M K 2021, ' Comparative analysis of stk11/lkb1 versus pten deficiency in lung adenocarcinoma induced by crispr/cas9 ', Cancers, vol. 13, no. 5, 974 . https://doi.org/10.3390/cancers13050974 Volume 13 Issue 5 Cancers, Vol 13, Iss 974, p 974 (2021)